Transforming the Management of Bleeding and Clotting
We seek to transform the way clinicians manage coagulation dysfunctions by providing comprehensive, timely information on coagulation status at the point of care. We have developed a next-generation near patient diagnostic platform that provides actionable information to guide the management of major bleeding and thrombosis enabling clinicians to choose the right treatment in the right time frame, dramatically improving outcomes.
Our innovative in vitro diagnostic platform characterizes hemostasis – the balance between bleeding and clotting – in a variety of acute care clinical settings.
HemoSonics is ISO certified under 13485:2016